A Severe Reaction After Phototherapy in a Neonate With X-Linked Protoporphyria

被引:0
|
作者
Sandgren, Jeremy A. [1 ]
Tung, Moon Ley [2 ]
Berrebi, Kristen G. [4 ]
Saade, Dimah N. [3 ]
Bermick, Jennifer R. [1 ]
Lee, Stephanie S. [1 ]
Stanford, Amy H. [1 ]
机构
[1] Univ Iowa, Div Neonatol, Iowa City, IA USA
[2] Univ Iowa, Div Med Genet & Genom, Iowa City, IA USA
[3] Univ Iowa, Dept Pediat, Div Pediat Neurol, Iowa City, IA USA
[4] Univ Iowa, Dept Dermatol & Pediat, Iowa City, IA USA
关键词
ERYTHROPOIETIC PROTOPORPHYRIA; COMPLEMENT;
D O I
10.1542/peds.2023-064724
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Protoporphyria is a subtype of porphyria characterized primarily by painful phototoxic skin reactions after light exposure at specific wavelengths. Historically, phototherapy is not contraindicated in patients with protoporphyria since there have not been any reports of phototoxic reactions. However, patients with protoporphyria are advised to avoid direct sunlight. In this case report, we describe a neonate not known to have X-linked protoporphyria who received phototherapy for 1 to 2 hours. Within hours after initiation of phototherapy, this neonate developed a life-threatening reaction consisting of rash over the distribution of phototherapy, acute liver failure with coagulopathy, diffuse hypotonia with diaphragmatic failure, and subsequent acute respiratory failure that required mechanical ventilation. As in this case, patients with protoporphyria-related acute liver failure can have signs and symptoms similar to that of an acute hepatic porphyria attack. Neither neonatal reactions to phototherapy nor liver failure temporally associated with phototherapy have been reported in patients with X-linked protoporphyria. Early recognition of this entity is crucial in light of potential life-threatening complications. Therefore, providers must react quickly when neonates have abnormal reactions to phototherapy and consider protoporphyria in the differential diagnosis.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] LIVER INVOLVEMENT IN ERYTHROPOIETIC PROTOPORPHYRIA AND X-LINKED PROTOPORPHYRIA
    Levy, Cynthia
    Naik, Hetanshi
    Overbey, Jessica
    Hedstrom, Karli
    Wang, Kelly
    Keel, Sioban
    Erwin, Angelica
    Dickey, Amy
    Wang, Bruce M.
    Phillips, John
    McGuire, Brendan M.
    Bonkovsky, Herbert L.
    Anderson, Karl E.
    Thapar, Manish
    Beaven, Simon W.
    Saberi, Behnam
    Desnick, Robert J.
    Balwani, Manisha
    HEPATOLOGY, 2022, 76 : S1517 - S1518
  • [2] Bone marrow transplant for X-linked protoporphyria with severe hepatic fibrosis
    Butler, David F.
    Ginn, Kevin F.
    Daniel, James F.
    Bloomer, Joseph R.
    Kats, Alexander
    Shreve, Nancy
    Myers, Gary D.
    PEDIATRIC TRANSPLANTATION, 2015, 19 (04) : E106 - E110
  • [3] X-linked dominant protoporphyria in the UK
    Whatley, S.
    Anstey, A.
    Badminton, M.
    Cole, D.
    Holme, A.
    Mason, N.
    Woolf, J.
    Elder, G. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (05) : 1141 - 1141
  • [4] How I treat erythropoietic protoporphyria and X-linked protoporphyria
    Leaf, Rebecca Karp
    Dickey, Amy K.
    BLOOD, 2023, 141 (24) : 2921 - 2931
  • [5] Homeostasis of Iron and Hepcidin in Erythropoietic Protoporphyria and X-Linked Protoporphyria
    Bossi, Krista
    Lee, Jingyun
    Schmeltzer, Paul
    Groseclose, Gale
    Besur, Siddesh
    Hwang, Sunil
    Bonkovsky, Herbert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S180 - S180
  • [6] Severe cutaneous manifestations in an Indian child with X-linked dominant erythropoietic protoporphyria
    Srinivas, Sahana
    Moss, Celia
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [7] X-linked dominant protoporphyria: a new porphyria
    Seager, M. J.
    Whatley, S. D.
    Anstey, A. V.
    Millard, T. P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (01) : 35 - 37
  • [8] X-linked myotubular myopathy in a neonate
    Mbou, FM
    Adjoua, S
    Elana, G
    MonlouisEugenie, M
    LeguyaderDesprees, P
    Bellance, R
    Piquion, N
    ARCHIVES DE PEDIATRIE, 1997, 4 (07): : 690 - 690
  • [9] Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria
    Madigan, Katelyn E.
    Rudnick, Sean R.
    Agnew, Matthew A.
    Urooj, Numra
    Bonkovsky, Herbert L.
    Mordon, Serge
    Rossi, Luigia
    PHARMACEUTICALS, 2024, 17 (01)
  • [10] A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
    Balwani, Manisha
    Naik, Hetanshi
    Overbey, Jessica R.
    Bonkovsky, Herbert L.
    Bissell, D. Montgomery
    Wang, Bruce
    Phillips, John D.
    Desnick, Robert J.
    Anderson, Karl E.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2022, 33